206 related articles for article (PubMed ID: 8628979)
1. Review of clinical trials and benefit/risk ratio of meloxicam.
Barner A
Scand J Rheumatol Suppl; 1996; 102():29-37. PubMed ID: 8628979
[TBL] [Abstract][Full Text] [Related]
2. Safety of meloxicam: a global analysis of clinical trials.
Distel M; Mueller C; Bluhmki E; Fries J
Br J Rheumatol; 1996 Apr; 35 Suppl 1():68-77. PubMed ID: 8630641
[TBL] [Abstract][Full Text] [Related]
3. Meloxicam: selective COX-2 inhibition in clinical practice.
Furst DE
Semin Arthritis Rheum; 1997 Jun; 26(6 Suppl 1):21-7. PubMed ID: 9219316
[TBL] [Abstract][Full Text] [Related]
4. Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritis.
Dequeker J; Hawkey C; Kahan A; Steinbrück K; Alegre C; Baumelou E; Bégaud B; Isomäki H; Littlejohn G; Mau J; Papazoglou S
Br J Rheumatol; 1998 Sep; 37(9):946-51. PubMed ID: 9783758
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment.
Hawkey C; Kahan A; Steinbrück K; Alegre C; Baumelou E; Bégaud B; Dequeker J; Isomäki H; Littlejohn G; Mau J; Papazoglou S
Br J Rheumatol; 1998 Sep; 37(9):937-45. PubMed ID: 9783757
[TBL] [Abstract][Full Text] [Related]
6. A six-month double-blind trial to compare the efficacy and safety of meloxicam 7.5 mg daily and naproxen 750 mg daily in patients with rheumatoid arthritis.
Wojtulewski JA; Schattenkirchner M; Barceló P; Le Loët X; Bevis PJ; Bluhmki E; Distel M
Br J Rheumatol; 1996 Apr; 35 Suppl 1():22-8. PubMed ID: 8630632
[TBL] [Abstract][Full Text] [Related]
7. Meloxicam.
Fleischmann R; Iqbal I; Slobodin G
Expert Opin Pharmacother; 2002 Oct; 3(10):1501-12. PubMed ID: 12387696
[TBL] [Abstract][Full Text] [Related]
8. Meloxicam.
Noble S; Balfour JA
Drugs; 1996 Mar; 51(3):424-30; discussion 431-32. PubMed ID: 8882380
[TBL] [Abstract][Full Text] [Related]
9. Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam.
Singh G; Lanes S; Triadafilopoulos G
Am J Med; 2004 Jul; 117(2):100-6. PubMed ID: 15234645
[TBL] [Abstract][Full Text] [Related]
10. A double-blind study to compare the efficacy and safety of meloxicam 15 mg with piroxicam 20 mg in patients with osteoarthritis of the hip.
Lindén B; Distel M; Bluhmki E
Br J Rheumatol; 1996 Apr; 35 Suppl 1():35-8. PubMed ID: 8630634
[TBL] [Abstract][Full Text] [Related]
11. Tolerability of multiple administration of intramuscular meloxicam: a comparison with intramuscular piroxicam in patients with rheumatoid arthritis or osteoarthritis.
Ghozlan PR; Bernhardt M; Vélicitat P; Bluhmki E
Br J Rheumatol; 1996 Apr; 35 Suppl 1():51-5. PubMed ID: 8630638
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed celecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data.
Layton D; Hughes K; Harris S; Shakir SA
Rheumatology (Oxford); 2003 Nov; 42(11):1332-41. PubMed ID: 12810929
[TBL] [Abstract][Full Text] [Related]
13. Meloxicam in rheumatoid arthritis.
Ahmed M; Khanna D; Furst DE
Expert Opin Drug Metab Toxicol; 2005 Dec; 1(4):739-51. PubMed ID: 16863437
[TBL] [Abstract][Full Text] [Related]
14. Meloxicam in osteoarthritis: a 6-month, double-blind comparison with diclofenac sodium.
Hosie J; Distel M; Bluhmki E
Br J Rheumatol; 1996 Apr; 35 Suppl 1():39-43. PubMed ID: 8630635
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, randomized trial to compare meloxicam 15 mg with diclofenac 100 mg in the treatment of osteoarthritis of the knee.
Goei Thè HS; Lund B; Distel MR; Bluhmki E
Osteoarthritis Cartilage; 1997 Jul; 5(4):283-8. PubMed ID: 9404473
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, randomized, placebo-controlled study of efficacy and tolerance of meloxicam treatment in patients with osteoarthritis of the knee.
Lund B; Distel M; Bluhmki E
Scand J Rheumatol; 1998; 27(1):32-7. PubMed ID: 9506875
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of meloxicam in an observational, controlled cohort study in patients with rheumatic disease.
Degner F; Sigmund R; Zeidler H
Clin Ther; 2000 Apr; 22(4):400-10. PubMed ID: 10823362
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of meloxicam in the treatment of osteoarthritis: a 12-week, double-blind, multiple-dose, placebo-controlled trial. The Meloxicam Osteoarthritis Investigators.
Yocum D; Fleischmann R; Dalgin P; Caldwell J; Hall D; Roszko P
Arch Intern Med; 2000 Oct; 160(19):2947-54. PubMed ID: 11041902
[TBL] [Abstract][Full Text] [Related]
19. An open study to assess the safety and tolerability of meloxicam 15 mg in subjects with rheumatic disease and mild renal impairment.
Bevis PJ; Bird HA; Lapham G
Br J Rheumatol; 1996 Apr; 35 Suppl 1():56-60. PubMed ID: 8630639
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of meloxicam in patients with rheumatoid arthritis.
Lemmel EM; Bolten W; Burgos-Vargas R; Platt P; Nissilä M; Sahlberg D; Björneboe O; Baumgartner H; Valat JP; Franchimont P; Bluhmki E; Hanft G; Distel M
J Rheumatol; 1997 Feb; 24(2):282-90. PubMed ID: 9034984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
